Hepatic resection for inflammatory hepatocellularadenomas: Pathological identification ofmicronodules expressing inflammatory proteins

Liver International

Volumn 30, Issue 1, 2010, Pages 149-154

  Bioulac Sage, Paulette ^a,b   Laumonier, Hervé ^c   Cubel, Gaelle ^b   Rossi, Jessica Zucman ^d,e   Balabaud, Charles ^b,c  

^a HÔPITAL PELLEGRIN   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

^d Université Paris 13   (France)

^e UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

Hepatocellular adenoma; Inflammatory hepatocellular adenoma; Micro liver adenoma

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LIVER ADENOMA; LIVER SURGERY; TUMOR VOLUME;

ADENOMA, LIVER CELL; ADULT; C-REACTIVE PROTEIN; FEMALE; FOCAL NODULAR HYPERPLASIA; HEPATECTOMY; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER NEOPLASMS; MIDDLE AGED; SERUM AMYLOID A PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 73349135949     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02098.x     Document Type: Article

References (12)

1. Bioulac-Sage P, Rebouissou S, Sa Cunha A, et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005; 128: 1211-8.
2. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with H.C.C. Hepatology 2006; 43: 515-24.
3. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007; 46: 740-8.
4. Rebouissou S, Amessou M, Couchy G, et al. Frequent inframe somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009; 457: 200-4.
5. Paradis V, Champault A, Ronot M, et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007; 46: 140-6.
6. Laumonier H, Bioulac-Sage P, Laurent C, et al. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008; 48: 808-18.
7. Flejou JF, Barge J, Menu Y, et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985; 89: 1132-8.
8. Laumonier H, Rullier A, Saric J, Balabaud C, Bioulac-Sage P. Unexpected discovery of 2 cases of hepatocyte nuclear factor 1alpha-mutated infracentimetic adenomatosis. World J Gastroenterol 2008; 14: 4830-3.
9. Lepreux S, Laurent C, Blanc JF, et al. The identification of small nodules in liver adenomatosis. J Hepatol 2003; 39: 77-85.
10. van der Windt DJ, Kok NF, Hussain SM, et al. Caseorientated approach to the management of hepatocellular adenoma. Br J Surg 2006; 93: 1495-502.
11. Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009; 50: 481-9.
12. Veteläinen R, Erdogan D, de Graaf W, et al. Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 2008; 28: 499-508.